Altamira Therapeutics Extends Bentrio Distribution Agreement With Pharma Nordic To Include Sweden And Denmark
Portfolio Pulse from Benzinga Newsdesk
Altamira Therapeutics has extended its distribution agreement with Pharma Nordic to include Sweden and Denmark for its Bentrio nasal spray, following a successful launch in Norway.
August 23, 2024 | 1:04 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Altamira Therapeutics has expanded its distribution agreement with Pharma Nordic to include Sweden and Denmark for its Bentrio nasal spray, indicating potential growth in market reach and revenue.
The extension of the distribution agreement to Sweden and Denmark suggests an increase in market reach for Altamira's Bentrio product, which could lead to higher revenues. The successful launch in Norway supports the potential for success in these new markets.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100